Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Canertinib |
Trade Name | |
Synonyms | CI-1033 |
Drug Descriptions |
Canertinib (CI-1033) is a pan-ERBB inhibitor that inhibits EGFR, ERBB2 (HER2), ERBB3 (HER3), and ERBB4 (HER4) signaling, which may result in decreased tumor growth (PMID: 11706399, PMID: 17342332, PMID: 30425998). |
DrugClasses | EGFR Inhibitor (Pan) 62 HER inhibitor (Pan) 6 |
CAS Registry Number | 267243-28-7 |
NCIT ID | C77588 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Canertinib | Canertinib | 0 | 0 |
Canertinib + MRTX-1133 | Canertinib MRTX-1133 | 0 | 0 |